Purple Biotech Ltd (PPBT)
NASDAQ: PPBT · Real-Time Price · USD
4.540
-0.235 (-4.92%)
At close: Mar 9, 2026, 4:00 PM EDT
4.330
-0.210 (-4.63%)
After-hours: Mar 9, 2026, 5:57 PM EDT
Purple Biotech Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 6 | 11 | 22 | 27 | 68 | 67 | |
| Market Cap Growth | -33.95% | -48.88% | -19.26% | -60.77% | 1.95% | 364.71% | |
| Enterprise Value | -5 | 5 | 5 | -6 | 22 | -0 | |
| Last Close Price | 4.54 | 46.90 | 156.00 | 276.00 | 778.00 | 762.00 | |
| PB Ratio | 0.18 | 0.34 | 0.63 | 0.57 | 1.05 | 0.84 | |
| P/TBV Ratio | 1.22 | 2.21 | 3.52 | 1.02 | 1.54 | 1.14 | |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Net Debt / Equity Ratio | -0.31 | -0.25 | -0.44 | -0.67 | -0.71 | -0.71 | |
| Net Debt / EBITDA Ratio | 2.04 | 0.78 | 0.68 | 1.41 | 2.63 | 4.39 | |
| Net Debt / FCF Ratio | 1.54 | 0.58 | 0.76 | 1.89 | 3.02 | 4.65 | |
| Quick Ratio | 1.73 | 2.14 | 1.59 | 4.55 | 11.11 | 18.82 | |
| Current Ratio | 1.78 | 2.23 | 1.63 | 4.71 | 11.41 | 19.14 | |
| Return on Equity (ROE) | -10.48% | -21.66% | -49.09% | -38.79% | -24.61% | -63.35% | |
| Return on Assets (ROA) | -8.48% | -16.60% | -28.14% | -22.63% | -14.55% | -16.74% | |
| Return on Capital Employed (ROCE) | -15.20% | -32.70% | -64.40% | -47.50% | -27.20% | -16.40% | |
| Earnings Yield | -54.04% | -65.38% | -91.76% | -80.75% | -26.88% | -41.74% | |
| FCF Yield | -109.75% | -129.73% | -91.98% | -62.47% | -22.47% | -18.26% | |
| Buyback Yield / Dilution | -106.88% | -48.17% | -22.41% | -2.92% | -52.76% | -493.78% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.